Site içinde arama yapın

Vikas Kokate bir ses eklendi Other
2025-07-30 10:58:44 -

Gastroesophageal Junction Adenocarcinoma Therapeutics Market Overview, Growth Analysis, Trends and Forecast By 2032
"Executive Summary Gastroesophageal Junction Adenocarcinoma Therapeutics Market : During the forecast period of 2025 to 2032 the market is likely to grow at a CAGR of 17.56%, primarily driven by the rising prevalence and treatments advancements Gastroesophageal Junction Adenocarcinoma Therapeutics Market report provides the market potential for each geographical region...

0 Yorumlar 0 hisse senetleri 1K Views 0 önizleme

Please log in to like, share and comment!
Ksh Dbmr bir ses eklendi Networking
2026-03-16 06:27:38 -

How Are Targeted Cancer Therapies Driving Innovation in the Hormone-Refractory Oncology Drug Market?
Demand Outlook for Executive Summary Hormone-Refractory Oncology Drug Market Market Size and Share CAGR Value The global hormone-refractory oncology drug market size was valued at USD 5.33 billion in 2025 and is expected to reach USD 12.46 billion by 2033, at a CAGR of 11.20% during the forecast period The wide-ranging report deals with the new business challenges and investment...

0 Yorumlar 0 hisse senetleri 112 Views 0 önizleme

Please log in to like, share and comment!
Ksh Dbmr bir ses eklendi Networking
2026-03-09 08:19:19 -

How Is the Essential Thrombocytosis Treatment Market Advancing Rare Blood Disorder Care?
Detailed Analysis of Executive Summary Essential Thrombocytosis Treatment Market Size and Share CAGR Value The global essential thrombocytosis treatment market size was valued at USD 968.50 Million in 2025 and is expected to reach USD 1509.03 Million by 2033, at a CAGR of 5.70% during the forecast period The Essential Thrombocytosis Treatment report provides market shares at global...

0 Yorumlar 0 hisse senetleri 205 Views 0 önizleme

Please log in to like, share and comment!